Hyperhidrosis: an update on prevalence and severity in the United States
- PMID: 27744497
- PMCID: PMC5099353
- DOI: 10.1007/s00403-016-1697-9
Hyperhidrosis: an update on prevalence and severity in the United States
Abstract
Current published estimates of the prevalence of hyperhidrosis in the United States are outdated and underestimate the true prevalence of the condition. The objectives of this study are to provide an updated estimate of the prevalence of hyperhidrosis in the US population and to further assess the severity and impact of sweating on those affected by the condition. For the purposes of obtaining prevalence, a nationally representative sample of 8160 individuals were selected using an online panel, and information as to whether or not they experience hyperhidrosis was obtained. The 393 individuals (210 female, 244 non-Hispanic white, 27 black, mean age 40.3, SE 0.64) who indicated that they have hyperhidrosis were asked further questions, including body areas impacted, severity of symptoms, age of onset, and socioemotional impact of the condition. Current results estimate the prevalence of hyperhidrosis at 4.8 %, which represents approximately 15.3 million people in the United States. Of these, 70 % report severe excessive sweating in at least one body area. In spite of this, only 51 % have discussed their excessive sweating with a healthcare professional. The main reasons are a belief that hyperhidrosis is not a medical condition and that no treatment options exist. The current study's findings with regard to age of onset and prevalence by body area generally align with the previous research. However, current findings suggest that the severity and prevalence are both higher than previously thought, indicating a need for greater awareness of the condition and its associated treatment options among medical professionals.
Keywords: Excessive sweating; Hyperhidrosis; Impact; Prevalence; Severity.
Conflict of interest statement
Current research was conducted by Burke Inc. with funding provided by Brickell Biotech, a pharmaceutical company focused on the development of treatments for dermatologic diseases and conditions. Burke Inc. assumed primary responsibility for recruiting of respondents and data analysis.
References
-
- Bahar R, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH) J Am Acad Dermatol. 2016 - PubMed
-
- Caplin D, Austin J. Clinical evaluation and quantitative analysis of axillary hyperhidrosis treated with a unique targeted laser energy delivery method with 1-year follow up. J Drugs Dermatol. 2014;13:449–456. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
